JESSICA LONG: Open Payments
NPI 1194244707 · EAGLE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 23 payments from 10 companies in 2025. Trend: 2023 $70 · 2024 $380 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 8 | $140 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| Novo Nordisk Inc | 3 | $56 |
| ABBVIE INC. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $35 |
| Reprise Biomedical, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $16 |
| Stryker Corporation | 1 | $14 |
Products named: INGREZZA, QULIPTA, KEVEYIS, Miro3D, Cologuard Collection Kit, Wegovy, AUSTEDO XR, Rybelsus.
Industry payments across ID — which companies pay providers there.
